Open Question

Can a standardized multiparametric protocol reliably separate benign from malignant vertebral marrow across vendors?

Evidence grade: MODERATE — Supported by moderate evidence.

Why it matters

Targets non-standard ADC thresholds; high staging stakes (S05, SG3)

Open in the interactive atlas →

About this page

Curated and maintained by Resonant Labs. Reviewed by Claims are synthesized from the cited literature and graded per the Atlas methodology (about the Atlas). Last updated 2026-07-14.

This is an educational research resource from Resonant Labs, not clinical advice. Evidence grades and controversies are summarized from the literature and may change as the field evolves.